Finished
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
NCT04992026 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated 5 Dec 2024
- What is being tested
- robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissection; 1.Abiraterone Acetate Tablets; Prednisone Acetate Tablets; Luteinizing Hormone-Releasing Hormone Analog
- For
- Prostatectomy; Oligometastatic Prostate Cancer; Abiraterone
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 40 years to 75 years. About 130 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Jan 2021, ends 2 Dec 2024. Registered 5 Aug 2021.
- Results
- None posted yet.
In the researchers' words
This randomized, controlled, multi-center clinical trial aims to evaluate the efficacy and safety of prostatectomy for castration-Naive oligometastatic prostate cancer
Sites
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNanjing, Jiangsu, China